Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3754914

COc1ccc(C(C(N)=O)N(C)C)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 0.44
DPP7 Q9UHL4 2/20 0.44
ALOX5 P09917 1/20 0.43
DPP8 Q6V1X1 1/20 0.42
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
ATM Q13315 1/20 0.41
TRPM8 Q7Z2W7 2/20 0.40
AOC3 Q16853 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP2 Q9UGN5 1/20 0.40
PARP4 Q9UKK3 1/20 0.40
LDHA P00338 1/20 0.40
HPGD P15428 1/20 0.39
EPHX1 P07099 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11928257 0.89 ALOX5 (0.50) ALOX5TRPM8AOC3CA1CA2
Trifluoroacetic Acid SCHEMBL3754919 0.79 ALDH1A1 (0.49) DPP4DPP7OPRM1OPRD1ATM
SCHEMBL2091000 0.78 LDHA (0.49) ALOX5AOC3CA1CA2LDHA
SCHEMBL13661683 0.75 ACACB (0.46) ALOX5AOC3CA1CA2NPSR1
Trifluoroacetic Acid SCHEMBL2422885 0.74 DPP4 (0.48) DPP4DPP7DPP8LDHANPSR1
Hydrochloric Acid SCHEMBL7261129 0.73 ACACB (0.45) ALOX5AOC3NPSR1
Trifluoroacetic Acid SCHEMBL1842699 0.73 TDP1 (0.61) CA1CA2PARP1PARP10PARP2
SCHEMBL4152158 0.72 TRPM8 (0.56) ALOX5TRPM8EPHX1
SCHEMBL29173115 0.72 TRPM8 (0.57) TRPM8AOC3PARP1
SCHEMBL29173116 0.72 TRPM8 (0.57) TRPM8AOC3PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7838518-B2 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders N.V. ORGANON (NL) 2010-11-23 US disclosed
US-20050154023-A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders MERCK SHARP & DOHME B.V. (NL) 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154023-A1 1-arylsulfonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders TPH1, HTR1A, HTR1D DPP4 2972/4885DPP7 3003/4885ALOX5 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.